Showing results (861-870 of 917) with videos related to

Sort By:
Pageof 92
Archives of Cardiovascular Diseases|April 21, 2024
Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular ejection fraction) studyJean-Sébastien Hulot, Philip Janiak, Philippe Boutinaud, et al.
Science (New York, N.Y.)|December 14, 2004
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosisKoen Andries, Peter Verhasselt, Jerome Guillemont, et al.
Journal for Immunotherapy of Cancer|January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitorsJulien Taieb, Margherita Ambrosini, Emily Alouani, et al.
Journal of Synchrotron Radiation|January 5, 2023
BioSAXS at European Synchrotron Radiation Facility - Extremely Brilliant Source: BM29 with an upgraded source, detector, robot, sample environment, data collection and analysis softwareMark D Tully, Jerome Kieffer, Martha E Brennich, et al.
Oncoimmunology|February 27, 2026
Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancerBenoît Lecoester, Yaoyao Xie, Xushan Sun, et al.
Future Oncology (London, England)|November 12, 2024
Phase I/II study of trifluridine/tipiracil plus XB2001 versus trifluridine/tipiracil in metastatic colorectal cancerJean-David Fumet, Nicolas Roussot, Aurélie Bertaut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2014
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II studyE Van Cutsem, C Boni, J Tabernero, et al.
Eclinicalmedicine|June 8, 2026
Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61-FUNGEMAX trial (France)Julien Taieb, Simon Pernot, Frédéric Thuillier, et al.
Transfusion|May 29, 2000
High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donorsJ J Lefrère, A Sender, B Mercier, et al.
Plos One|February 24, 2018
The first in vivo multiparametric comparison of different radiation exposure biomarkers in human bloodAles Tichy, Sylwia Kabacik, Grainne O'Brien, et al.
Pageof 92